Fizostigmin

Fizostigmin
(IUPAC) ime
	(3aR,8aS)-1,3a,8-Trimetil-1H,2H,3H,3aH,8H,8aH-pirolo[2,3-b]indol-5-il N-metilkarbamat
Klinički podaci
Robne marke	Antilirium
AHFS/Drugs.com	Monografija
Identifikatori
CAS broj	57-47-6
ATC kod	S01EB05 V03AB19
PubChem	5983
DrugBank	DB00981
ChemSpider	5763
UNII	9U1VM840SP
KEGG	D00196
ChEBI	CHEBI:27953
ChEMBL	CHEMBL94
Hemijski podaci
Formula	C15H21N3O2
Mol. masa	275,346 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C15H21N3O2/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6,9,13H,7-8H2,1-4H3,(H,16,19)/t13-,15+/m1/s1 ; Key: PIJVFDBKTWXHHD-HIFRSBDPSA-N
Farmakokinetički podaci
Metabolizam	Glavni metabolit: Eserolin
Farmakoinformacioni podaci
Trudnoća	C(US)
Pravni status	℞-only (SAD)
Način primene	intravenonozno, intramuskularno, ofthalmički

Fizostigmin (eserin) je parasimpatomimetski alkaloid. On je reverzibilni inhibitor holinesteraze.

Ova supstanca je sintetisana 1935. Dostupna je pod imenima: Antilirium, Isopto Eserine, Eserin salicilat i Eserin sulfat.

Farmakologija

Fizostigmin deluje tako što ometa metabolizam acetilholina. On je kovalentni (reverzibilni - veza se hidrolizuje) inhibitor acetilholinsteraze, enzima odgovornog za razlaganje acetilholina u sinaptičkim rascepima neuromuskularnih spojeva.^[6] On indirektno stimuliše nikotinske i muskarinske receptore.

Biosinteza

Biosinteza fizostigmina je predložena počevši od triptaminske metilacije i postheterociklizacije katalisane nepoznatim enzimom:

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ Katzung, B. G.; Masters, S.; Trever, A. (2009). Basic and Clinical Pharmacology. McGraw Hill. str. 110. ISBN 978-0-07-160405-5.

Povezano

Cimserin

Spoljašnje veze

	Portal Medicina
	Portal Hemija

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

[5] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[6] Katzung, B. G.; Masters, S.; Trever, A. (2009). Basic and Clinical Pharmacology. McGraw Hill. str. 110. ISBN 978-0-07-160405-5.

[1]

[2]

[3]

[4]

[5]

[6]